CLOV rides 38% Medicare Advantage growth and rising EBITDA, but higher medical costs and policy risks cloud its near-term margin outlook.

Management cited drivers for improved profitability, including "strong 2025 execution," "strong returning member retention during AEP," 4-star PPO payment year, favorable rate dynamics, expanded ...

Milan Korcok examines cost containment tools, fraud control, and the digitisation of healthcare across the Americas, as ...

In 2025, both new and returning member cohort contribution profit performed in line with expectations. Returning member contribution profit remained strong at $200 PMPM year-over-year. New member ...

My husband, Jason, is a retired veteran and never enrolled in Medicare because he uses the VA for his medical care and ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Jefferson Health Plans added nearly 12,000 new customers to its Medicare Advantage plans during the open enrollment period ...

Don't blow a big opportunity.

The government is imposing strict new limits on Medicare Advantage Plan coverage for 2026, and retirees need to be aware of ...

Medicare Advantage enrollment declines in seven states as growth slows to 2.5% in 2026 amid health plan exits and market shifts.

Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% ...

Clover Health Investments (NASDAQ:CLOV) executives used the company’s fourth-quarter 2025 earnings call to emphasize a ...